LUCENTIS - RANIBIZUMAB
Navigation: NDC > Supplier starting with: G > GENENTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 50242-082 |
| Proprietary Name: | LUCENTIS |
| Suffix: | |
| Non-Proprietary Name: | RANIBIZUMAB |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVITREAL |
| Original Marketing Date: | 10-08-2012 |
| Category Name: | BLA |
| Application Number: | BLA125156 |
| Labeler: | GENENTECH, INC. |
| Substance Name: | RANIBIZUMAB |
| Active Numerator Strength: | 6 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Vascular Endothelial Growth Factor Receptor Inhibitors [MoA],Vascular Endothelial Growth Factor-directed Antibody [EPC],Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA] |
| DEA Schedule: |